Influence of Hepatitis B Virus Genetic Heterogeneity on Treatment Response Against Lamivudine and Interferon in Pakistani Isolates

Publisher： Bentham Science Publishers

E-ISSN： 2211-3533|14|2|121-125

ISSN： 2211-3525

Source： Anti-Infective Agents, Vol.14, Iss.2, 2016-09, pp. : 121-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon plus lamivudine may be effective in patients with dual hepatitis B virus (HBV) and hepatitis C virus (HCV) infection

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Lamivudine for the treatment of chronic hepatitis B

By Sokal Etienne  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 329-339

Informa Healthcare

Access to resources Recommend Favorite

Sustained response to lamivudine in chronic hepatitis B

By  

Inpharma, Vol. 1, Iss. 1387, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

The Immune Responsiveness in Hepatitis C Virus Infected Patients: Effects of Interferon-Alfa / Ribavirin Combined Treatment on the Lymphocyte Response with Special Reference to B Cells

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-01 ,pp. : 2093-2100

Bentham Science Publishers

Access to resources Recommend Favorite

A Preliminary Benefit-Risk Assessment of Lamivudine for the Treatment of Chronic Hepatitis B Virus Infection

By Zoulim F.  

Drug Safety, Vol. 25, Iss. 7, 2002-01 ,pp. : 497-510

Adis International

Access to resources Recommend Favorite